#gskplc — Public Fediverse posts

Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?

GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #Jemperli #NYSE
https://www.europesays.com/britain/117964/

https://www.europesays.com/britain/117964/ Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity? #GSK #GSKPlc #Jemperli #NYSE

Panmure and Cavendish reiterate buy on Hutchmed after GSK deal

Panmure and Cavendish reiterate buy on Hutchmed after GSK deal Proactive uses images sourced from Shutterstock Hutchmed (China)…
#EuropeSays #Britain #Europe #EU #GSK #Cavendish #GSKplc #Hutchmed #Panmure #PanmureLiberum
https://www.europesays.com/britain/116928/

https://www.europesays.com/britain/116928/ Panmure and Cavendish reiterate buy on Hutchmed after GSK deal #Cavendish #GSK #GSKPlc #Hutchmed #Panmure #PanmureLiberum

https://www.europesays.com/britain/116414/ GSK Says Immune Response from mRNA Flu Shot Surpasses Licensed Competitors #Benzinga #BenzingaPro #GSK #GSKPlc #TheUSFoodAndDrugAdministration

GSK’s sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer

GSK plc GSK announced that the FDA has accepted for review its supplemental biologics license application (sBLA) seeking approval…
#EuropeSays #Britain #Europe #EU #GSK #AnikaTherapeutics #FDA #GSKplc #Jemperli #NationalPriorityVoucher #OncologyDrug #rectalcancer #sBLA #ZacksInvestmentResearch
https://www.europesays.com/britain/110015/

https://www.europesays.com/britain/110015/ GSK’s sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer #AnikaTherapeutics #FDA #GSK #GSKPlc #Jemperli #NationalPriorityVoucher #OncologyDrug #RectalCancer #sBLA #ZacksInvestmentResearch

GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth

GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth Proactive uses images…
#EuropeSays #Britain #Europe #EU #GSK #AccelerateGrowth #Citi #earningsgrowth #GSKplc #GSKshares #PhaseIIItrials
https://www.europesays.com/britain/109949/

https://www.europesays.com/britain/109949/ GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth #AccelerateGrowth #Citi #EarningsGrowth #GSK #GSKPlc #GSKShares #PhaseIIITrials

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #PhaseIIItrial
https://www.europesays.com/britain/103070/

https://www.europesays.com/britain/103070/ Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era? #GSK #GSKPlc #PhaseIIITrial

GSK plc reports 13F portfolio of 13 holdings | GSK SEC Filing

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined…
#EuropeSays #Britain #Europe #EU #GSK #13Fholdingsreport #602220442totalvalue #GSKplc #institutionalinvestmentmanager #SECfiling #SECForm13F #USequityportfolio
https://www.europesays.com/britain/103040/

https://www.europesays.com/britain/103040/ GSK plc reports 13F portfolio of 13 holdings | GSK SEC Filing #13FHoldingsReport #602220442TotalValue #GSK #GSKPlc #InstitutionalInvestmentManager #SECFiling #SECForm13F #USEquityPortfolio

GSK executives acquire shares via reward plan | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #InsiderTransactions #JulieBrown #LondonStockExchange #LynnBaxter #ordinaryshares #sharerewardplan
https://www.europesays.com/britain/102909/

https://www.europesays.com/britain/102909/ GSK executives acquire shares via reward plan | GSK SEC Filing #GSK #GSKPlc #InsiderTransactions #JulieBrown #LondonStockExchange #LynnBaxter #OrdinaryShares #ShareRewardPlan

GSK executive acquires notional ADS in savings plan | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE…
#EuropeSays #Britain #Europe #EU #GSK #ADSacquisition #AmericanDepositaryShares #executivesupplementalsavingsplan #Form6-K #GSKplc #insidertransaction
https://www.europesays.com/britain/101397/

https://www.europesays.com/britain/101397/ GSK executive acquires notional ADS in savings plan | GSK SEC Filing #ADSAcquisition #AmericanDepositaryShares #ExecutiveSupplementalSavingsPlan #Form6K #GSK #GSKPlc #InsiderTransaction

GSK updates total voting rights for July 2026 | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE…
#EuropeSays #Britain #Europe #EU #GSK #DisclosureGuidanceandTransparencyRules #Form6-K #GSKplc #ordinaryshares #sharecapital #shareholdernotifications #totalvotingrights #treasuryshares #UKlisting
https://www.europesays.com/britain/99948/

https://www.europesays.com/britain/99948/ GSK updates total voting rights for July 2026 | GSK SEC Filing #DisclosureGuidanceAndTransparencyRules #Form6K #GSK #GSKPlc #OrdinaryShares #ShareCapital #ShareholderNotifications #TotalVotingRights #TreasuryShares #UKListing

GSK hits three-month high as vaccines help earnings top forecasts

GSK hits three-month high as vaccines help earnings top forecasts Proactive uses images sourced from Shutterstock GSK PLC…
#EuropeSays #Britain #Europe #EU #GSK #earningspershare #GSKplc #respiratorysyncytialvirus #Vaccines
https://www.europesays.com/britain/98728/

https://www.europesays.com/britain/98728/ GSK hits three-month high as vaccines help earnings top forecasts #EarningsPerShare #GSK #GSKPlc #RespiratorySyncytialVirus #Vaccines

https://www.europesays.com/britain/97431/ AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report #AstraZeneca #AstraZenecaPLC #BiotechAndPharmaceuticals #BristolMyersSquibbCo #Business #BusinessNews #GileadSciencesInc #GSKPlc #HealthCareIndustry #InvescoPharmaceuticalsETF #ISharesUSPharmaceuticalsETF #MergersAndAcquisitions #PfizerInc #Pharmaceuticals #SpdrS&PBiotechEtf #SpdrS&PPharmaceuticalsEtf #UnitedStates

GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline …

This article first appeared on GuruFocus. Revenue: Q2 sales up 5% to more than GBP8.4 billion. Core Operating…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #Q2sales
https://www.europesays.com/britain/93411/

https://www.europesays.com/britain/93411/ GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline … #GSK #GSKPlc #Q2Sales

GSK Beats Second-Quarter Forecasts and Unveils £1.9 Billion Efficiency Programme

GSK ©Adobe Stock Images GSK Plc (LSE:GSK) reported stronger-than-expected second-quarter results on Tuesday, driven by continued momentum in…
#EuropeSays #Britain #Europe #EU #GSK #clinicaldevelopment #GSKplc #restructuringcosts #Vaccines
https://www.europesays.com/britain/92505/

https://www.europesays.com/britain/92505/ GSK Beats Second-Quarter Forecasts and Unveils £1.9 Billion Efficiency Programme #ClinicalDevelopment #GSK #GSKPlc #RestructuringCosts #Vaccines

https://www.europesays.com/britain/92377/ GSK Q2 2026: core profits rise, EPS hit by charges | GSK SEC Filing #AccelerateGrowthProgramme #CamlipixantImpairment #CoreEPS505p #FreeCashFlow #GSK #GSK2026Q2Results #GSKPlc #Pharmaceuticals #QuarterlyEarnings

GSK to build new £400m Cambridge R&D centre | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #biopharmaresearch #CambridgeBiomedicalCampus #Form6-K #GSKplc #Stevenagesite #UKR&Dinvestment #Warelaboratories
https://www.europesays.com/britain/92346/

https://www.europesays.com/britain/92346/ GSK to build new £400m Cambridge R&D centre | GSK SEC Filing #BiopharmaResearch #CambridgeBiomedicalCampus #Form6K #GSK #GSKPlc #StevenageSite #UKR&DInvestment #WareLaboratories

GSK admits 70,759 new shares to London market | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #admissiontotrading #blocklisting #Form6-K #GSKplc #LondonStockExchange #ordinaryshares #ShareSavePlan2022
https://www.europesays.com/britain/89766/

Eli Lilly makes a new push into vaccines – here’s what to know

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
#NewsBeep #News #Healthcare #AU #Australia #BiotechandPharmaceuticals #businessnews #EliLillyandCo #GSKplc #Health #Healthcareindustry #ModernaInc #RobertF.KennedyJr. #Socialissues
https://www.newsbeep.com/au/698169/

Is Britain back? Five things to watch for the U.K. in 2026

This report is from this week’s CNBC’s UK Exchange newsletter. Like what you see? You can subscribe here. …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Economy #BPPLC #British10YearGilt #Business #businessnews #China #CristianoAmon #DiageoPLC #donaldtrump #Economicevents #FTSE100 #GBP/USD #GSKplc #KeirStarmer #PerellaWeinbergPartners #SevernTrentPLC #ToyotaMotorCorp. #WalterIsaacson
https://www.newsbeep.com/us/393030/

Markets could face ‘everything bubble’ as selloff rages on

Global stocks have fluctuated wildly over the past week, as concerns abou…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Artificialintelligence #AI #AlphabetClassA #ArtificialIntelligence #businessnews #GSKplc #Investmentstrategy #Markets #MetaPlatformsInc #MicrosoftCorp #NewYork #NovoNordiskA/S #NVIDIACorp #regwall-pro #RocheHoldingAG #Stockmarkets #Technology #TeslaInc #WorldMarkets
https://www.newsbeep.com/us/310462/

Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs

https://web.brid.gy/r/https://www.nytimes.com/2025/09/26/business/europe-pharma-tariffs-trump.html

Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs

https://web.brid.gy/r/https://www.nytimes.com/2025/09/26/business/europe-pharma-tariffs-trump.html